Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A novel hyperactive BCR::ABL1 e6a3 variant confers resistance to combined asciminib plus ponatinib therapy.
Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026
The Emergence of Inpatient Sleep Medicine: Screening for Sleep Disordered Breathing to Reduce the Burden of Cardiovascular Disease.
Journal: Current sleep medicine reports
Published: August 26, 2024
Target volume coverage in clinically designed radiotherapy plan of post-mastectomy adjuvant radiotherapy of breast cancer patients in comparison with radiation therapy oncology group-based contoured plan: A dosimetric study.
Journal: Journal of cancer research and therapeutics
Published: June 14, 2023
MAPK-negative feedback regulation confers dependence to JAK2V617F signaling.
Journal: Leukemia
Published: February 05, 2023
Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor.
Journal: Leukemia
Published: January 30, 2023
Highly aggressive gastric adenocarcinoma with multiple skin nodule and supraclavicular node in a 19-year-old patient: A rare presentation in such young age.
Journal: Journal of cancer research and therapeutics
Published: April 06, 2022
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.
Journal: Blood advances
Published: March 04, 2022
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review.
Journal: World journal of gastrointestinal endoscopy
Published: February 28, 2022
The GIST of It: A Rare Presentation of Neurofibromatosis Type I.
Journal: Cureus
Published: June 29, 2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AML.
Journal: Blood advances
Published: March 01, 2021
Last Updated: 09/26/2026